Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Leonard Trahan

Anesthesiology Kingwood, TX Medical Doctor

NPI 1073504247 CMS profile 93432

24018 Highway 59 N, Kingwood, TX 77339

Open in the dashboard

General payments

$8,323

225 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leonard Trahan of Kingwood, TX is reported in the CMS Open Payments database as having received $8,323 across 225 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $566 31
2024 General $1,726 72
2023 General $566 20
2022 General $618 30
2021 General $472 26
2020 General $194 9
2019 General $4,180 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leonard Trahan
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Leonard Trahan were reported at $566. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Leonard Trahan Anesthesiology median Middle half National median
2019 $4,180 $72 $23–$151 $163
2020 $194 $36 $17–$120 $114
2021 $472 $49 $21–$135 $132
2022 $618 $52 $22–$144 $149
2023 $566 $53 $23–$143 $160
2024 $1,726 $55 $25–$150 $164
2025 $566 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $4,642 73 payments
  2. Medtronic, Inc. $1,954 92 payments
  3. Abbott Laboratories $860 31 payments
  4. SPR Therapeutics, Inc $193 2 payments
  5. MML US, Inc. $123 1 payment
  6. Relievant Medsystems, Inc. $80 2 payments
  7. Medtronic USA, Inc. $71 3 payments
  8. Stryker Corporation $71 2 payments
  9. SI-BONE, Inc. $45 2 payments
  10. Nevro Corp. $44 2 payments
  11. Other $238 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,835 223 payments
  2. Consulting Fee $3,200 1 payment
  3. Travel and Lodging $288 1 payment
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER $3,532 5 payments
  2. INTELLIS ADAPTIVESTIM $1,653 81 payments
  3. PROCLAIM $427 9 payments
  4. GENERAL PAIN MANAGEMENT $391 38 payments
  5. General - Pain Management $195 13 payments
  6. SPRINT PNS System $193 2 payments
  7. GENERAL THERAPIES $183 1 payment
  8. INTELLIS $162 3 payments
  9. ReActiv8 $123 1 payment
  10. ETERNA $119 6 payments
  11. Other $1,297 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

1,225

Median for Anesthesiology: 322

Drug cost

$29,641

Median for Anesthesiology: $8,738

Branded share of claims

64.3%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 585 $15,793
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 163 $5,665
Fentanyl Generic 19 $2,382
Gabapentin Generic 92 $1,328
Tizanidine Hcl Generic 58 $997
Pregabalin Generic 44 $581
Tramadol Hcl Generic 53 $501
Morphine Sulfate Generic 19 $475
Methylprednisolone Generic 66 $414
Cyclobenzaprine Hcl Generic 24 $334

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$207,160

Of which drugs: $81

Medicare patients

429

Average age 75

Services billed

1,895

245 women, 184 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 41%
Diabetes 38%
Depression 30%
Chronic kidney disease 29%
COPD 25%
Heart failure 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 24 105 $81

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

225 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record